116 related articles for article (PubMed ID: 12467213)
1. Molecular and cellular characterization of imexon-resistant RPMI8226/I myeloma cells.
Dvorakova K; Payne CM; Tome ME; Briehl MM; Vasquez MA; Waltmire CN; Coon A; Dorr RT
Mol Cancer Ther; 2002 Jan; 1(3):185-95. PubMed ID: 12467213
[TBL] [Abstract][Full Text] [Related]
2. Induction of mitochondrial changes in myeloma cells by imexon.
Dvorakova K; Waltmire CN; Payne CM; Tome ME; Briehl MM; Dorr RT
Blood; 2001 Jun; 97(11):3544-51. PubMed ID: 11369649
[TBL] [Abstract][Full Text] [Related]
3. Induction of oxidative stress and apoptosis in myeloma cells by the aziridine-containing agent imexon.
Dvorakova K; Payne CM; Tome ME; Briehl MM; McClure T; Dorr RT
Biochem Pharmacol; 2000 Sep; 60(6):749-58. PubMed ID: 10930529
[TBL] [Abstract][Full Text] [Related]
4. Imexon activates an intrinsic apoptosis pathway in RPMI8226 myeloma cells.
Dvorakova K; Payne CM; Landowski TH; Tome ME; Halperin DS; Dorr RT
Anticancer Drugs; 2002 Nov; 13(10):1031-42. PubMed ID: 12439337
[TBL] [Abstract][Full Text] [Related]
5. Imexon-induced apoptosis in multiple myeloma tumor cells is caspase-8 dependent.
Evens AM; Prachand S; Shi B; Paniaqua M; Gordon LI; Gartenhaus RB
Clin Cancer Res; 2004 Feb; 10(4):1481-91. PubMed ID: 14977852
[TBL] [Abstract][Full Text] [Related]
6. Correlates of imexon sensitivity in human multiple myeloma cell lines.
Samulitis BK; Landowski TH; Dorr RT
Leuk Lymphoma; 2006 Jan; 47(1):97-109. PubMed ID: 16321833
[TBL] [Abstract][Full Text] [Related]
7. The antitumor agent imexon activates antioxidant gene expression: evidence for an oxidative stress response.
Baker AF; Landowski T; Dorr R; Tate WR; Gard JM; Tavenner BE; Dragovich T; Coon A; Powis G
Clin Cancer Res; 2007 Jun; 13(11):3388-94. PubMed ID: 17545547
[TBL] [Abstract][Full Text] [Related]
8. Imexon-based combination chemotherapy in A375 human melanoma and RPMI 8226 human myeloma cell lines.
Scott J; Dorr RT; Samulitis B; Landowski TH
Cancer Chemother Pharmacol; 2007 May; 59(6):749-57. PubMed ID: 17333195
[TBL] [Abstract][Full Text] [Related]
9. Green tea component, catechin, induces apoptosis of human malignant B cells via production of reactive oxygen species.
Nakazato T; Ito K; Ikeda Y; Kizaki M
Clin Cancer Res; 2005 Aug; 11(16):6040-9. PubMed ID: 16115949
[TBL] [Abstract][Full Text] [Related]
10. The small-molecule Bcl-2 inhibitor HA14-1 interacts synergistically with flavopiridol to induce mitochondrial injury and apoptosis in human myeloma cells through a free radical-dependent and Jun NH2-terminal kinase-dependent mechanism.
Pei XY; Dai Y; Grant S
Mol Cancer Ther; 2004 Dec; 3(12):1513-24. PubMed ID: 15634644
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of survivin via activation of ERK1/2, Akt, and NF-κB plays a central role in vincristine resistance in multiple myeloma cells.
Tsubaki M; Takeda T; Ogawa N; Sakamoto K; Shimaoka H; Fujita A; Itoh T; Imano M; Ishizaka T; Satou T; Nishida S
Leuk Res; 2015 Apr; 39(4):445-52. PubMed ID: 25726084
[TBL] [Abstract][Full Text] [Related]
12. Induction of apoptosis and cell cycle arrest by imexon in human pancreatic cancer cell lines.
Dorr RT; Raymond MA; Landowski TH; Roman NO; Fukushima S
Int J Gastrointest Cancer; 2005; 36(1):15-28. PubMed ID: 16227632
[TBL] [Abstract][Full Text] [Related]
13. [Targeting miR155 restores chemotherapy sensitivity in drug-resistant myeloma cell-line RPMI8226/DOX cells].
Xiao CR; Hong XL; Hu JS; Chen YM; Lu QY
Zhonghua Xue Ye Xue Za Zhi; 2017 Jan; 38(1):55-59. PubMed ID: 28219227
[No Abstract] [Full Text] [Related]
14. CSTMP induces apoptosis and mitochondrial dysfunction in human myeloma RPMI8226 cells via CHOP-dependent endoplasmic reticulum stress.
Sun X; Liao W; Wang J; Wang P; Gao H; Wang M; Xu C; Zhong Y; Ding Y
Biomed Pharmacother; 2016 Oct; 83():776-784. PubMed ID: 27490778
[TBL] [Abstract][Full Text] [Related]
15. PJ34, a poly(ADP-ribose) polymerase (PARP) inhibitor, reverses melphalan-resistance and inhibits repair of DNA double-strand breaks by targeting the FA/BRCA pathway in multidrug resistant multiple myeloma cell line RPMI8226/R.
Xiong T; Wei H; Chen X; Xiao H
Int J Oncol; 2015 Jan; 46(1):223-32. PubMed ID: 25351371
[TBL] [Abstract][Full Text] [Related]
16. Autophagy in drug resistance of the multiple myeloma cell line RPMI8226 to doxorubicin.
Pan YZ; Wang X; Bai H; Wang CB; Zhang Q; Xi R
Genet Mol Res; 2015 May; 14(2):5621-9. PubMed ID: 26125760
[TBL] [Abstract][Full Text] [Related]
17. [Caspase-independent apoptosis induced by arsenic trioxide in human multiple myeloma cell RPMI8226].
Xie J; Zhang M; Song YP; Hu K; Ren JJ; Zhang YJ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Feb; 20(1):107-11. PubMed ID: 22391177
[TBL] [Abstract][Full Text] [Related]
18. Rituximab modifies the cisplatin-mitochondrial signaling pathway, resulting in apoptosis in cisplatin-resistant non-Hodgkin's lymphoma.
Alas S; Ng CP; Bonavida B
Clin Cancer Res; 2002 Mar; 8(3):836-45. PubMed ID: 11895917
[TBL] [Abstract][Full Text] [Related]
19. Upregulated expression of BCL-2 in multiple myeloma cells induced by exposure to doxorubicin, etoposide, and hydrogen peroxide.
Tu Y; Xu FH; Liu J; Vescio R; Berenson J; Fady C; Lichtenstein A
Blood; 1996 Sep; 88(5):1805-12. PubMed ID: 8781438
[TBL] [Abstract][Full Text] [Related]
20. [Effects of docetaxel on proliferation and apoptosis of human multiple myeloma cell RPMI8226].
Liu BL; Liu X; Qi MY; Zhou NC; Xu B
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Dec; 20(6):1378-83. PubMed ID: 23257437
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
